Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy
S Takahashi - Biological and Pharmaceutical Bulletin, 2011 - jstage.jst.go.jp
… They neutralize VEGF-A, resulting in prevention of tumor angiogenesis. VEGFR tyrosine …
tumor therapy by inhibiting VEGFR signaling. Anti-VEGF drugs are a promising therapy for …
tumor therapy by inhibiting VEGFR signaling. Anti-VEGF drugs are a promising therapy for …
The role of fibroblast growth factors in tumor growth
M Korc, RE Friesel - Current cancer drug targets, 2009 - ingentaconnect.com
… in designing new drug therapies to target FGF receptor (… endothelial growth factor (VEGF) to
amplify tumor angiogenesis… tumor growth and angiogenesis than targeting either factor alone…
amplify tumor angiogenesis… tumor growth and angiogenesis than targeting either factor alone…
Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy
C Timke, H Zieher, A Roth, K Hauser, KE Lipson… - Clinical cancer …, 2008 - AACR
… of radiation markedly enhanced the therapeutic efficacy in all … ) tumors growing sc on BALB/c
nu/nu mice. This study shows that radiation is an integral component of local tumor therapy …
nu/nu mice. This study shows that radiation is an integral component of local tumor therapy …
Vascular endothelial growth factor as a target for anticancer therapy
N Ferrara - The oncologist, 2004 - academic.oup.com
… tumor angiogenesis are regulated by a host of growth factors … others, such as basic fibroblast
growth factor (bFGF) and the … Activating factors can be produced by the tumors themselves…
growth factor (bFGF) and the … Activating factors can be produced by the tumors themselves…
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin, LM Ellis - Journal of clinical oncology, 2005 - ascopubs.org
… of growth factor receptor pathways that promote tumor angiogenesis. … growth factor (VEGF)
family of proteins and receptors. … with tumor progression and poor prognosis in several tumor …
family of proteins and receptors. … with tumor progression and poor prognosis in several tumor …
Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase …
JM Schlaeppi, JM Wood - Cancer and Metastasis Reviews, 1999 - Springer
… of tumor cells. In vivo, PTK787/ZK 222584 inhibited VEGFinduced angiogenesis in a growth
factor implant model as well as tumor … the subcutaneous growth of a variety of human tumor …
factor implant model as well as tumor … the subcutaneous growth of a variety of human tumor …
Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy
HF Dvorak - Journal of clinical oncology, 2002 - ascopubs.org
… platelet-derived growth factor (PDGF) superfamily of growth factors. Other members of the
VEGF family include VEGF-B, VEGF-C, VEGF-D, and VEGF-E and placenta growth factor (PlGF…
VEGF family include VEGF-B, VEGF-C, VEGF-D, and VEGF-E and placenta growth factor (PlGF…
Tumor angiogenesis and accessibility: role of vascular endothelial growth factor
RK Jain - Seminars in oncology, 2002 - Elsevier
… is the vascular endothelial growth factor (VEGF, also known as vascular permeability factor
[VPF], or … Vascular endothelial growth factor is both a vascular growth factor and a vascular …
[VPF], or … Vascular endothelial growth factor is both a vascular growth factor and a vascular …
Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy
Y Liu, Y Li, Y Wang, C Lin, D Zhang, J Chen… - Journal of Hematology & …, 2022 - Springer
… therapy of the dual epidermal growth factor … tumor in phase II clinical trial (NCT00326495).
Secondly, aberrant expression of VEGFR and genetic alteration of fibroblast growth factor …
Secondly, aberrant expression of VEGFR and genetic alteration of fibroblast growth factor …
Connective tissue growth factor–specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis
N Dornhofer, S Spong, K Bennewith, A Salim, S Klaus… - Cancer research, 2006 - AACR
… to most existing therapies. Past studies have shown that connective tissue growth factor (CTGF) …
and how CTGF influences tumor growth, we generated pancreatic tumor cell lines that …
and how CTGF influences tumor growth, we generated pancreatic tumor cell lines that …
相关搜索
- cancer therapy growth factor receptor
- vascular endothelial growth factor
- connective tissue growth factor
- fibroblast growth factor
- growth factor receptor inhibitors
- tumor cell growth factor
- tumor radiation response growth factors
- growth factor tumor vessels
- therapeutic target growth factor receptor
- growth factor tumor angiogenesis
- cancer cells tissue growth factor
- growth factor antiangiogenic tumor therapy
- growth factor anti-tumor therapy
- cartilaginous tumors tissue growth factor
- antibody therapy tissue growth factor
- growth factor target for anticancer therapy